OMCL

Omnicell, Inc. (OMCL)

Healthcare • Health Information Services

StockNasdaqGSUnited StatesUS68213N1090

34.87 USD -0.24% today Updated 13 Nov 2026 16:23

Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Omnicell, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.

Price history

Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.

All time

Updated 13 Nov 2026 16:23. Information, not advice. Showing the last 12 months. Create a free account to see the whole history

Results

Next results 04 Feb 2027 in 83 days · 08:00 · estimate 0.42

Last results 0.58 vs 0.42 estimated 29 Oct 2026 · Beat +38.9%

Beat the estimate 11 of 12 1 missed · 0 in line · 3 beats in a row

Average surprise +71.5% reported against the estimate, last 12 quarters

Earnings per share: estimate and reported

Estimate Reported: beat Reported: miss In line

Quarterly results

Date	EPS estimate	EPS reported	Surprise	Result
04 Feb 2027 08:00	0.42	—	—	Upcoming
29 Oct 2026 06:00	0.42	0.58	+38.9%	Beat
30 Jul 2026 06:00	0.47	0.94	+101.1%	Beat
28 Apr 2026 06:00	0.33	0.55	+66.0%	Beat
05 Feb 2026 06:00	0.50	0.40	-19.4%	Miss
30 Oct 2025 06:00	0.36	0.51	+40.7%	Beat
31 Jul 2025 06:00	0.27	0.45	+66.7%	Beat
06 May 2025 06:00	0.20	0.26	+27.1%	Beat
06 Feb 2025 06:00	0.58	0.60	+2.8%	Beat
30 Oct 2024 06:00	0.42	0.56	+33.6%	Beat
01 Aug 2024 06:00	0.14	0.51	+253.5%	Beat
02 May 2024 07:00	-0.09	0.03	+132.0%	Beat
08 Feb 2024 08:00	0.15	0.33	+114.5%	Beat
02 Nov 2023 08:00	0.48	0.62	+30.5%	Beat
01 Aug 2023 16:00	0.28	0.57	+101.8%	Beat
02 May 2023 16:00	0.07	0.39	+476.7%	Beat
28 Feb 2023 16:00	0.08	0.33	+301.4%	Beat
02 Nov 2022 08:00	0.95	1.00	+4.8%	Beat
04 Aug 2022 16:00	0.85	0.84	-1.2%	Miss
28 Apr 2022 16:00	0.68	0.83	+22.1%	Beat
14 Feb 2022 16:00	0.92	0.92	-0.3%	In line
02 Nov 2021 07:00	0.91	1.08	+18.4%	Beat
29 Jul 2021 08:00	0.83	0.97	+17.3%	Beat
29 Apr 2021 16:00	0.66	0.83	+26.4%	Beat
01 Feb 2021 16:00	0.82	0.91	+11.2%	Beat
27 Oct 2020 16:00	0.49	0.60	+23.2%	Beat
28 Jul 2020 16:00	0.23	0.37	+63.9%	Beat
07 May 2020 17:00	0.51	0.66	+29.0%	Beat
06 Feb 2020 16:00	0.78	0.77	-1.5%	Miss
24 Oct 2019 16:00	0.71	0.76	+6.8%	Beat
25 Jul 2019 16:00	0.63	0.67	+5.6%	Beat
25 Apr 2019 16:00	0.41	0.61	+50.4%	Beat
07 Feb 2019 16:00	0.67	0.70	+5.2%	Beat
25 Oct 2018 16:00	0.56	0.63	+13.4%	Beat
26 Jul 2018 16:00	0.39	0.46	+16.7%	Beat
26 Apr 2018 16:00	0.25	0.29	+14.7%	Beat
01 Feb 2018 16:00	0.52	0.54	+4.1%	Beat
26 Oct 2017 16:00	0.42	0.42	+0.7%	In line
27 Jul 2017 16:00	0.23	0.31	+32.3%	Beat
04 May 2017 08:00	0.02	0.06	+200.0%	Beat
15 Feb 2017 11:00	0.41	0.37	-9.8%	Miss
27 Oct 2016 16:00	0.41	0.40	-1.5%	Miss
28 Jul 2016 16:00	0.32	0.38	+18.8%	Beat
28 Apr 2016 16:00	0.26	0.35	+32.4%	Beat
04 Feb 2016 16:00	0.39	0.40	+1.8%	Beat
29 Oct 2015 16:00	0.36	0.36	-0.4%	In line
30 Jul 2015 16:00	0.33	0.28	-14.3%	Miss
30 Apr 2015 16:00	0.23	0.29	+24.3%	Beat
03 Feb 2015 16:00	0.34	0.39	+15.4%	Beat
30 Oct 2014 16:00	0.31	0.30	-3.6%	Miss

Annual results · USD

Year	Revenue	Change	Net income	Net margin	EPS	EPS change	Free cash flow
2025	1.2B	+6.5%	2.1M	0.2%	0.04	-85.2%	69.4M
2024	1.1B	-3.0%	12.5M	1.1%	0.27	+160.0%	134.9M
2023	1.1B	-11.5%	-20.4M	-1.8%	-0.45	-475.0%	126.1M
2022	1.3B	—	5.6M	0.4%	0.12	—	17M

Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.

Prices by day, week and month

Day Week Month

Price history in USD, by month
Period	Opening price	High	Low	Closing price	Change	Volume
Nov 2026 In progress	36.78	40.10	34.59	34.87	-4.87%	5,959,539
Oct 2026	34.02	38.50	33.07	36.65	+7.64%	11,472,600
Sep 2026	34.70	35.61	31.98	34.05	-3.16%	12,008,700
Aug 2026	35.53	38.00	32.53	35.16	-0.59%	14,741,700
Jul 2026	41.10	48.06	35.00	35.37	-14.81%	17,193,600
Jun 2026	44.14	44.72	36.55	41.52	-5.94%	16,415,200
May 2026	41.72	45.00	41.23	44.14	+6.57%	9,978,600
Apr 2026	33.80	46.89	32.74	41.42	+24.09%	11,891,200
Mar 2026	40.13	42.43	31.75	33.38	-18.78%	13,725,200
Feb 2026	49.09	50.19	35.38	41.10	-15.26%	18,229,600
00 Mon 0000	157.29	236.48	315.67	394.86	+0.00%	000,000
00 Mon 0000	553.24	632.43	711.62	790.81	+0.00%	000,000
00 Mon 0000	49.19	128.38	207.57	286.76	+0.00%	000,000
51 older periods: create a free account to see the whole history

Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.

News

Buy These 3 Stocks with Broker Rating Upgrades for Big Gains (opens in a new tab) Zacks · 10 Nov 2026 17:41
4 Undervalued Stocks That Could Benefit from a Wall Street Rally (opens in a new tab) Zacks · 10 Nov 2026 17:38
Learn Why The Bull Case For Omnicell (OMCL) Could Change Following Raised Revenue Guidance (opens in a new tab) Simply Wall St. · 07 Nov 2026 12:12
Why Omnicell (OMCL) Might be Well Poised for a Surge (opens in a new tab) Zacks · 05 Nov 2026 16:20
OMCL vs. VEEV: Which Stock Should Value Investors Buy Now? (opens in a new tab) Zacks · 05 Nov 2026 15:40
Top Robotics Stocks With Strong Potential for Long-Term Growth (opens in a new tab) Zacks · 05 Nov 2026 15:33
Best Momentum Stocks to Buy for November 5th (opens in a new tab) Zacks · 05 Nov 2026 14:00
Does Omnicell (OMCL) Have the Potential to Rally 40.83% as Wall Street Analysts Expect? (opens in a new tab) Zacks · 05 Nov 2026 13:55
New Strong Buy Stocks for November 5th (opens in a new tab) Zacks · 05 Nov 2026 10:27
Best Value Stocks to Buy for November 5th (opens in a new tab) Zacks · 05 Nov 2026 06:51
OMCL Q3 deep dive: disciplined cost control offsets flat sales, software transition in early innings (opens in a new tab) StockStory · 02 Nov 2026 22:05
Omnicell’s Q3 earnings call: our top 5 analyst questions (opens in a new tab) StockStory · 02 Nov 2026 15:25
Omnicell (OMCL) Q3 Earnings Lift Profit Outlook As Margins Firm (opens in a new tab) Simply Wall St. · 30 Oct 2026 13:12
Omnicell, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 30 Oct 2026 01:22
Omnicell Q3 Earnings Call Highlights (opens in a new tab) MarketBeat · 29 Oct 2026 21:14

Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.

Key data

Previous close: 34.95 USD
Market cap: 1.6B
Exchange: NasdaqGS
Country: United States
Sector: Healthcare
Industry: Health Information Services
Currency: USD

Dividends

No dividends on record.

Why this score

How the score is made up
Part of the score	Points	Why
Business growth Yearly growth of revenue and of earnings per share.	0.0 / 25	Revenue growth of -2.9% a year Earnings per share growth of -30.7% a year
Quality Return on equity, net margin and how stable the margins are.	8.6 / 25	ROE of 4%
Financial strength Net debt against operating earnings, interest cover and free cash flow.	20.0 / 20	Net debt is -1.3× EBITDA Free cash flow yield of 8.3%
Valuation Free cash flow yield and the P/E against its sector.	10.6 / 15	P/E 37.4 against 30.6 for its sector
Analysts How far the analysts' average target is from today's price.	10.0 / 10	Analysts' target is +65% from the price

Growth profile: it pays no dividend, so it is scored on business growth, quality and financial strength. Based on 95% of the figures (grade A).

Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio. How the score works

Figures

Valuation
Figure	Value	Reading	Sector median
P/E (trailing)	37.4×	Weak	30.56×
P/E (forward)	17.87×	Fair	14.16×
Price / book	1.25×	Good	3.5×
Price / sales	1.33×	Good	3.33×
EV / EBITDA	18.25×	Weak	11.19×
Free cash flow yield	8.3%	Good	2.1%

Quality
Figure	Value	Reading	Sector median
Gross margin	44.4%	Good	54.9%
Operating margin	4.9%	Weak	5.8%
Net margin	3.6%	Weak	1.2%
Return on equity	3.5%	Weak	4.4%
Return on assets	1.8%	Weak	2.7%

Growth
Figure	Value	Reading	Sector median
Revenue growth / year	-2.9%	Weak	10.1%
EPS growth / year	-30.7%	Weak	10.2%

Financial health
Figure	Value	Reading	Sector median
Debt / equity	0.15×	Good	0.4×
Net debt / EBITDA	-1.3×	Good	1.46×
Current ratio	1.66×	Good	2.64×

Dividends
Figure	Value	Reading	Sector median
Payout of earnings	0%	Weak	0%

The reading follows general rules of thumb and each sector has its own norms: compare with the sector median when it is shown. Information, not advice.

Similar shares

Follow OMCL and get alerts

Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.

Start for free Log in